Korean Coronary Bifurcation Stenting (COBIS) Registry II

Completed

• Conditions: Coronary Bifurcation Lesion

• Registration Number: NCT01642992
• Lead Sponsor: Hyeon-Cheol Gwon

Brief Summary

The COBIS II registry is a multi-center, real-world registry of drug-eluting stenting in coronary bifurcation lesions in South Korea. From 18 major coronary intervention centers in Korea, a total of 2,873 patients were enrolled in this database between January 2003 and December 2009.

The aim of the study was to investigate long-term clinical results and predictors of adverse outcomes after percutaneous coronary intervention with drug-eluting stents for coronary bifurcation lesions in South Korea.

Detailed Description

Not available

Study Timeline

• Study Start: 2011-01
• Primary Completion: 2012-04
• Study Completion: 2012-04
• Study First Submitted: 2012-07-15
• Study First Submitted QC: 2012-07-15
• Study First Posted: 2012-07-17
• Status Verified: 2013-01
• Last Update Submitted: 2013-01-09
• Last Update Posted: 2013-01-10

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 2873

Inclusion Criteria

• Age >= 18 years
• Any type of bifurcation lesion in major epicardial artery
• Side branch reference diameter >= 2.3 mm and at least stentable with 2.5 mm stent
• Treated with drug-eluting stent

Exclusion Criteria

• Protected left main disease previous CABG for LAD or LCX territory
• Cardiogenic Shock
• History of CPR in the same hospitalization

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Incidence of the composite outcomes of cardiac death, target vessel-related myocardial infarction, or target-lesion revascularization	3 years

Secondary Outcome Measures

Name	Time	Method
Cardiac death	3 years
Myocardial infarction	3 years
Target lesion revascularization	3 years
Stent thrombosis	3 years

Trial Locations

Locations (1)

Samsung Medical Center; 🇰🇷 Seoul, Korea, Republic of